News
The FDA has approved Yeztugo, a twice-yearly HIV injection by Gilead shown to virtually eliminate new infections.
Trump ordered a 90-day pause on foreign aid after taking office in January and halted grants by the U.S. Agency for ...
Trump administration’s financial cuts to HIV services impact Southern Arizona AIDS Foundation ...
Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...
The Southern Eye The information was released during a recent National Aids Council (Nac) media sensitisation workshop held ...
Greek City Times Scientists Delete HIV from Human Cells in World-First Breakthrough Scientists have successfully deleted the ...
Newsday Zimbabwe Health and Child Care minister Douglas Mombeshora, however, was quick to allay the fears saying the increase ...
The FDA has approved Yeztugo, the first long-acting injectable PrEP shot, which could significantly impact HIV prevention ...
Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
7h
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results